Kidney Cancer Trial, Recruiting NCT06889974 Sponsor: University Hospital, Bordeaux Condition: Kidney Cancer
Back to Kidney Cancer

Kidney Cancer Trial, Recruiting

NCT06889974
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults who are 18 years of age or older
  • People who were admitted to an intensive care unit (ICU) at some point between January 1, 2013, and December 31, 2023
  • People who have been diagnosed with a blood cancer (such as leukemia or lymphoma) or a solid tumor that required chemotherapy treatment
  • People who developed a condition called tumor lysis syndrome (TLS) — this is when chemotherapy causes cancer cells to break down quickly, releasing substances into the blood that cause abnormal levels of certain minerals — confirmed by at least two abnormal blood test results within 3 days before or 7 days after starting chemotherapy

Who may not be able to join:

  • People (or their family members) who have objected to their personal data being used for research purposes
  • People whose medical records are incomplete, making it impossible to gather the necessary information for the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 05 56 70 56 79

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
1 July 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Renal dysfunction at ICU discharge

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov